Generation Bio Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Generation Bio's estimated annual revenue is currently $16M per year.
- Generation Bio received $100.0M in venture funding in February 2018.
- Generation Bio's estimated revenue per employee is $155,000
- Generation Bio's total funding is $100M.
- Generation Bio has 103 Employees.
- Generation Bio grew their employee count by 18% last year.
- Generation Bio currently has 8 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Cell Signaling ...||$89.4M||577||N/A||N/A|
What Is Generation Bio?
Generation Bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. Our unique GeneWave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. We are a community of creative problem-solvers and independent thinkers. We are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. To learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our Twitter feed, @lifetimegeneTX.keywords:N/A
Number of Employees
Employee Growth %
|Tracy Zimmermann||Vice President, Preclinical Research And Translational Biology||Email Available|
|Matthew Stanton||Chief Scientific Officer|
|Carolyn Pelletier||Principal Associate Scientist|
|Raj Endran||Associate Director|
|Luckner Milord||Senior Director Of It|
|Robert Silva||Associate Director, Animal Care Facility|
|Matthew Simmons||Associate Director|
|Will Mccarthy||Chief Business Officer|
|Birte Nolting||Senior Principal Scienstist|
Generation Bio News
In the Netherlands, BioMCN converts crude glycerine into advanced second generation bio-methanol. In Canada, bio-methanol is being produced from ...
09, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), ... These data are related to the first-generation lipid nanoparticle (LNP) ...
... Next Generation Antibody Screening Technology at Symposia Across the US ... For additional information, please visit www.carterra-bio.com.
Generation Bio Funding
|2018-02-28||$100.0M||B||Fidelity Management & Research Company||Article|
Generation Bio Executive Hires
|2018-01-09||Geoffrey McDonough||President/Chief Executive Officer||Article|
|2018-04-10||Will McCarthy||Chief Business Officer||Article|
|2018-05-09||Sara Besten||Head of Human Resources||Article|
|2018-11-06||Antoinette Paone||Head of Regulatory Affairs||Article|